Inside the NHS hospital trialling psychedelics to treat depression

The debate about whether the NHS should use magic mushrooms to treat depression

Synthetic Psilocybin Shows Strong Results in Treatment-Resistant Depression Trials

Compass Pathways, a British biotech company, announced strong results from two late-stage trials showing that a synthetic form of psilocybin

USC launches first clinical trial of psilocybin therapy for mental health treatment

USC researchers at the Keck School of Medicine, the Brain and Creativity Institute, and the USC Norris Comprehensive Cancer Center have laun

Real-World Study Shows Psilocybin Improves Treatment-Resistant Depression Symptoms

A real-world study of psilocybin therapy for treatment-resistant depression (TRD) in routine clinical practice shows clinically meaningful i

Psilocybin's Impact on Depression and Anxiety in Cancer Patients: Study Findings

A randomized double-blind trial studied the effects of psilocybin on 51 cancer patients with symptoms of depression and anxiety. Results sho

A promising first for researchers probing mental illness